{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:36:07Z","timestamp":1777635367986,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09J18105-003"],"award-info":[{"award-number":["2018ZX09J18105-003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017XQC-2"],"award-info":[{"award-number":["2017XQC-2"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jim.2020.112871","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T02:35:21Z","timestamp":1601433321000},"page":"112871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Production and characterization of a neutralizing antibody against botulinum neurotoxin A"],"prefix":"10.1016","volume":"487","author":[{"given":"Xianghua","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunhui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuxi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weicai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jim.2020.112871_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003023","article-title":"Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain","volume":"3","author":"Adekar","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jim.2020.112871_bb0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jim.2020.112871_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10080310","article-title":"Botulinum neurotoxin diversity from a gene-centered view","volume":"10","author":"Benoit","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"21","key":"10.1016\/j.jim.2020.112871_bb0020","first-page":"2135","article-title":"Investigational heptavalent botulinum antitoxin (Hbat) to replace licensed botulinum antitoxin Ab and investigational botulinum antitoxin E (Reprinted from Mmwr, Vol 59, Pg 299, 2010)","volume":"303","author":"CDC","year":"2010","journal-title":"JAMA J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.jim.2020.112871_bb0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/hyb.2011.0032","article-title":"Epitope characterization of sero-specific monoclonal antibody to Clostridium botulinum neurotoxin type A","volume":"30","author":"Corbett","year":"2011","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/j.jim.2020.112871_bb0030","series-title":"Principles of Biotechnology","author":"Crawford","year":"2018"},{"issue":"10","key":"10.1016\/j.jim.2020.112871_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10100421","article-title":"Variations in the botulinum neurotoxin binding domain and the potential for novel therapeutics","volume":"10","author":"Davies","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"5773","key":"10.1016\/j.jim.2020.112871_bb0040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"Sv2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jim.2020.112871_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxicon.2013.01.007","article-title":"Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function","volume":"75","author":"Fischer","year":"2013","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.jim.2020.112871_bb0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pediatrneurol.2004.10.001","article-title":"Recent advances in infant botulism","volume":"32","author":"Fox","year":"2005","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.jim.2020.112871_bb0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/jacs.6b09534","article-title":"Glycans confer specificity to the recognition of ganglioside receptors by botulinum neurotoxin a","volume":"139","author":"Hamark","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.jim.2020.112871_bb0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1099\/jgv.0.000705","article-title":"Enterovirus 71 induces apoptosis by directly modulating the conformational activation of pro-apoptotic protein Bax","volume":"98","author":"Han","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.jim.2020.112871_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003369","article-title":"Identification of fibroblast growth factor receptor 3 (Fgfr3) as a protein receptor for botulinum neurotoxin serotype a (Bont\/a)","volume":"9","author":"Jacky","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.jim.2020.112871_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nsb879","article-title":"Translocation of botulinum neurotoxin light chain protease through the heavy chain channel","volume":"10","author":"Koriazova","year":"2003","journal-title":"Nat. Struct. Biol."},{"issue":"5","key":"10.1016\/j.jim.2020.112871_bb0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the Clostridial neurotoxins","volume":"291","author":"Lacy","year":"1999","journal-title":"J. Mol. Biol."},{"issue":"2\u20133","key":"10.1016\/j.jim.2020.112871_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pbiomolbio.2015.02.004","article-title":"Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin","volume":"117","author":"Lam","year":"2015","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"2\u20133","key":"10.1016\/j.jim.2020.112871_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pbiomolbio.2015.02.004","article-title":"Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin","volume":"117","author":"Lam","year":"2015","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jim.2020.112871_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmb.2006.09.084","article-title":"Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display","volume":"365","author":"Levy","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jim.2020.112871_bb0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.19.2.298-314.2006","article-title":"Laboratory diagnostics of botulism","volume":"19","author":"Lindstrom","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.jim.2020.112871_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012416","article-title":"Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity","volume":"5","author":"Mazuet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2020.112871_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4615-1891-4_11","article-title":"Protection strategies against botulinum toxin","volume":"383","author":"Middlebrook","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.jim.2020.112871_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161446","article-title":"Development of bermline-humanized antibodies neutralizing botulinum neurotoxin A and B","volume":"11","author":"Miethe","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jim.2020.112871_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tim.2004.08.002","article-title":"Presynaptic receptor arrays for Clostridial neurotoxins","volume":"12","author":"Montecucco","year":"2004","journal-title":"Trends Microbiol."},{"issue":"17","key":"10.1016\/j.jim.2020.112871_bb0120","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jim.2020.112871_bb0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbamem.2015.08.014","article-title":"On the translocation of botulinum and tetanus neurotoxins across the membrane of acidic intracellular compartments","volume":"1858","author":"Pirazzini","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.jim.2020.112871_bb0130","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/IAI.69.1.570-574.2001","article-title":"High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A","volume":"69","author":"Pless","year":"2001","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.jim.2020.112871_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013245","article-title":"Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A","volume":"5","author":"Prigent","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jim.2020.112871_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2008.03.003","article-title":"Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type a and their use in analysis of milk by sandwich Elisa","volume":"336","author":"Stanker","year":"2008","journal-title":"J. Immunol. Methods"},{"issue":"8","key":"10.1016\/j.jim.2020.112871_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000129","article-title":"Crystal structure of botulinum neurotoxin type a in complex with the cell surface co-receptor Gt1b - insight into the toxin-neuron interaction","volume":"4","author":"Stenmark","year":"2008","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.jim.2020.112871_bb0150","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.febslet.2014.02.034","article-title":"Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin a","volume":"588","author":"Strotmeier","year":"2014","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.jim.2020.112871_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090268","article-title":"Vaccines against botulism","volume":"9","author":"Sundeen","year":"2017","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.jim.2020.112871_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/erv.13.37","article-title":"What next for botulism vaccine development?","volume":"12","author":"Webb","year":"2013","journal-title":"Exp. Rev. Vaccines"},{"issue":"7","key":"10.1016\/j.jim.2020.112871_bb0165","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/AEM.67.7.3201-3207.2001","article-title":"Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A","volume":"67","author":"Wu","year":"2001","journal-title":"Appl. Environ. Microbiol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175920301654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175920301654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:24:53Z","timestamp":1777440293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175920301654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S0022175920301654"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2020.112871","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production and characterization of a neutralizing antibody against botulinum neurotoxin A","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2020.112871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112871"}}